Researcher profile
Tony Jourdan
Public evidence
6 connected articles
Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy.2023 · Europe PMCDo endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?2022 · Europe PMCChemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist.2022 · Europe PMCEndocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human.2021 · Europe PMCCB<sub>1</sub> R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky-Pudlak syndrome.2021 · Europe PMCDecreasing CB<sub>1</sub> receptor signaling in Kupffer cells improves insulin sensitivity in obese mice.2017 · Europe PMC
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.